Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non–small-cell lung cancer and a performance status of 2

R Lilenbaum, R Axelrod, S Thomas… - Journal of Clinical …, 2008 - ascopubs.org
… the efficacy of erlotinib and standard chemotherapy in the PS 2 … dose of erlotinib or standard
chemotherapy were considered … with chemotherapy were allowed to cross over to erlotinib

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a …

R Rosell, E Carcereny, R Gervais… - The lancet …, 2012 - thelancet.com
Erlotinib has been shown to improve progression-free survival compared with chemotherapy
when … the safety and efficacy of erlotinib compared with standard chemotherapy for first-line …

Erlotinib (Tarceva): an update on the clinical trial program

RS Herbst - Seminars in oncology, 2003 - Elsevier
… Lung Cancer Investigation), were designed to examine erlotinib in combination with
standard chemotherapeutic agents as first-line therapy for patients with advanced NSCLC. The …

Chemotherapy with erlotinib or chemotherapy alone in advanced non‐small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitors

SB Goldberg, GR Oxnard, S Digumarthy… - The …, 2013 - academic.oup.com
… with chemotherapy plus erlotinib rather than chemotherapy alone … We found that continuing
erlotinib with chemotherapy … prospective trial comparing chemotherapy with erlotinib and …

Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non–small-cell lung cancer

TSK Mok, YL Wu, CJ Yu, C Zhou, YM Chen… - Journal of Clinical …, 2009 - ascopubs.org
… of erlotinib and chemotherapy improves clinical outcomes versus chemotherapy alone in
unselected, chemotherapy-naïve … phase III trials. In these studies, concurrent administration of …

… NSCLC: platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials

JG Zhou, X Tian, X Wang, JH Tian, Y Wang, F Wang… - Medical oncology, 2015 - Springer
… We concluded that the erlotinib plus chemotherapy for … that erlotinib combined with
platinum-based chemotherapy was … compared with platinum-based chemotherapy alone regime. …

Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a …

T Ciuleanu, L Stelmakh, S Cicenas, S Miliauskas… - The lancet …, 2012 - thelancet.com
… tolerability of erlotinib compared with standard chemotherapy (… -line, platinum-doublet
chemotherapy. We also investigated … This prospective head-to-head trial was designed to assess …

Erlotinib, gefitinib, or chemotherapy for EGFR mutation-positive lung cancer?

T Mitsudomi - The Lancet Oncology, 2011 - thelancet.com
… in the Asian population, never-smokers, women, and patients with adenocarcinoma led
to the first phase 3 trial comparing an EGFR TKI with chemotherapy in the first-line setting. …

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a …

C Zhou, YL Wu, G Chen, J Feng, XQ Liu… - The lancet …, 2011 - thelancet.com
… We do not believe that there is a need to a head-to-head clinical trial between gefinitib
and erlotinib; rather, further investigation is needed into why responding patients develop …

TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non–small-cell lung cancer

RS Herbst, D Prager, R Hermann… - Journal of clinical …, 2005 - ascopubs.org
… This is a report of a phase III trial that evaluated whether concurrent administration of erlotinib
with standard chemotherapy could enhance survival in chemotherapy-naïve patients with …